Retraction Note: Buparlisib induces eukaryotic elongation factor-2 expression to cause treatment failure for lung cancer cells

DanPing Wang, ChenLi Su, Xiao Zhang, Wei Mao, XiaoQiang Dai, Li Xu, XiaoMin Si

Open source

DOI
10.1007/s00438-026-02522-z
Published
2026-09-18
Container
Molecular Genetics and Genomics
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s00438-026-02522-z,
  title = {Retraction Note: Buparlisib induces eukaryotic elongation factor-2 expression to cause treatment failure for lung cancer cells},
  author = {DanPing Wang and ChenLi Su and Xiao Zhang and Wei Mao and XiaoQiang Dai and Li Xu and XiaoMin Si},
  year = {2026},
  journal = {Molecular Genetics and Genomics},
  doi = {10.1007/s00438-026-02522-z},
  url = {https://doi.org/10.1007/s00438-026-02522-z}
}

RIS

TY  - JOUR
TI  - Retraction Note: Buparlisib induces eukaryotic elongation factor-2 expression to cause treatment failure for lung cancer cells
AU  - DanPing Wang
AU  - ChenLi Su
AU  - Xiao Zhang
AU  - Wei Mao
AU  - XiaoQiang Dai
AU  - Li Xu
AU  - XiaoMin Si
PY  - 2026
JO  - Molecular Genetics and Genomics
DO  - 10.1007/s00438-026-02522-z
UR  - https://doi.org/10.1007/s00438-026-02522-z
ER  - 

APA

Wang, D., Su, C., Zhang, X., Mao, W., Dai, X., Xu, L., & Si, X. (2026). Retraction Note: Buparlisib induces eukaryotic elongation factor-2 expression to cause treatment failure for lung cancer cells. Molecular Genetics and Genomics. https://doi.org/10.1007/s00438-026-02522-z

Source records